Microparticles in Cancer

 

 Permissions and Reprints

ABSTRACT

Microparticles (MP) are vesicular structures released from cells upon activation, malignant transformation, stress, or death. MP may be derived from the plasma membrane (shed microvesicles), produced by endosomal pathway (exosomes), or arise from membrane blebs of apoptotic cells. The terms microparticles or microvesicles (MV) are often used as general and interchangeable descriptors of all cellular vesicles, but a more rigorous terminology is still to be established. The cargo of MP/MV consists of proteins, lipids, and nucleic acids (DNA, mRNA, microRNA), all of which may be transferred horizontally between cells. In cancer, oncogenic pathways drive production of MP/MV, and oncoproteins may be incorporated into the cargo of MV (oncosomes). Oncogenic pathways may also stimulate production of MP/MV harboring tissue factor and involved in cancer coagulopathy. In addition, the cargo of MV may include several receptors, antigens, bioactive molecules, and other species capable of stimulating tumor progression, immunotolerance, invasion, angiogenesis, and metastasis. MP emanate not only from tumor cells but also from platelets, endothelium, and inflammatory cells. Indeed, circulating MP/MV harbor molecular information related to cancer-related processes and may serve as a reservoir of prognostic and predictive biomarkers to monitor genetic tumor progression, angiogenesis, thrombosis, and responses to targeted therapeutics.

REFERENCES

• 1 Citri A, Yarden Y. EGF-ERBB signalling: towards the systems level.  Nat Rev Mol Cell Biol. 2006;  7(7) 505-516
  CrossrefPubMedGoogle Scholar
• 2 Blume-Jensen P, Hunter T. Oncogenic kinase signalling.  Nature. 2001;  411(6835) 355-365
  CrossrefPubMedGoogle Scholar
• 3 Pawson T. Protein modules and signalling networks.  Nature. 1995;  373(6515) 573-580
  CrossrefPubMedGoogle Scholar
• 4 Houghton A M, Rzymkiewicz D M, Ji H et al. Neutrophil elastase-mediated degradation of IRS-1 accelerates lung tumor growth.  Nat Med. 2010;  16(2) 219-223
  CrossrefPubMedGoogle Scholar
• 5 Gillette J M, Larochelle A, Dunbar C E, Lippincott-Schwartz J. Intercellular transfer to signalling endosomes regulates an ex vivo bone marrow niche.  Nat Cell Biol. 2009;  11(3) 303-311
  CrossrefPubMedGoogle Scholar
• 6 Aharon A, Brenner B. The role of breast cancer cells microparticles in thrombogenicity following chemotherapy [abstract].  Thromb Res. 2010;  125 S179
  PubMedGoogle Scholar
• 7 Małecki J, Wiedłocha A, Wesche J, Olsnes S. Vesicle transmembrane potential is required for translocation to the cytosol of externally added FGF-1.  EMBO J. 2002;  21(17) 4480-4490
  CrossrefPubMedGoogle Scholar
• 8 Hunter T. Protein kinases and phosphatases: the yin and yang of protein phosphorylation and signaling.  Cell. 1995;  80(2) 225-236
  CrossrefPubMedGoogle Scholar
• 9 Heppner G H. Tumor cell societies.  J Natl Cancer Inst. 1989;  81(9) 648-649
  PubMedGoogle Scholar
• 10 Liotta L A, Kohn E C. The microenvironment of the tumour-host interface.  Nature. 2001;  411(6835) 375-379
  CrossrefPubMedGoogle Scholar
• 11 Rak J. Is cancer stem cell a cell, or a multicellular unit capable of inducing angiogenesis?.  Med Hypotheses. 2006;  66(3) 601-604
  CrossrefPubMedGoogle Scholar
• 12 Ratajczak J, Wysoczynski M, Hayek F, Janowska-Wieczorek A, Ratajczak M Z. Membrane-derived microvesicles: important and underappreciated mediators of cell-to-cell communication.  Leukemia. 2006;  20(9) 1487-1495
  CrossrefPubMedGoogle Scholar
• 13 Pilzer D, Gasser O, Moskovich O, Schifferli J A, Fishelson Z. Emission of membrane vesicles: roles in complement resistance, immunity and cancer.  Springer Semin Immunopathol. 2005;  27(3) 375-387
  CrossrefPubMedGoogle Scholar
• 14 Davis D M, Sowinski S. Membrane nanotubes: dynamic long-distance connections between animal cells.  Nat Rev Mol Cell Biol. 2008;  9(6) 431-436
  CrossrefPubMedGoogle Scholar
• 15 Sherer N M, Mothes W. Cytonemes and tunneling nanotubules in cell-cell communication and viral pathogenesis.  Trends Cell Biol. 2008;  18(9) 414-420
  CrossrefPubMedGoogle Scholar
• 16 Ahmed K A, Xiang J. Mechanisms of cellular communication through intercellular protein transfer.  J Cell Mol Med. 2010;  (January) 11-[Epub ahead of print]
  PubMedGoogle Scholar
• 17 Caumartin J, Lemaoult J, Carosella E D. Intercellular exchanges of membrane patches (trogocytosis) highlight the next level of immune plasticity.  Transpl Immunol. 2006;  17(1) 20-22
  CrossrefPubMedGoogle Scholar
• 18 Al-Nedawi K, Meehan B, Rak J. Microvesicles: messengers and mediators of tumor progression.  Cell Cycle. 2009;  8(13) 2014-2018
  CrossrefPubMedGoogle Scholar
• 19 Johnstone R M. Exosomes biological significance: a concise review.  Blood Cells Mol Dis. 2006;  36(2) 315-321
  CrossrefPubMedGoogle Scholar
• 20 Cocucci E, Racchetti G, Meldolesi J. Shedding microvesicles: artefacts no more.  Trends Cell Biol. 2009;  19(2) 43-51
  CrossrefPubMedGoogle Scholar
• 21 Takamori S, Holt M, Stenius K et al. Molecular anatomy of a trafficking organelle.  Cell. 2006;  127(4) 831-846
  CrossrefPubMedGoogle Scholar
• 22 Al-Nedawi K, Meehan B, Kerbel R S, Allison A C, Rak J. Endothelial expression of autocrine VEGF upon the uptake of tumor-derived microvesicles containing oncogenic EGFR.  Proc Natl Acad Sci U S A. 2009;  106(10) 3794-3799
  CrossrefPubMedGoogle Scholar
• 23 Al-Nedawi K, Meehan B, Micallef J et al. Intercellular transfer of the oncogenic receptor EGFRvIII by microvesicles derived from tumour cells.  Nat Cell Biol. 2008;  10(5) 619-624
  CrossrefPubMedGoogle Scholar
• 24 Yu J L, Rak J W. Shedding of tissue factor (TF)-containing microparticles rather than alternatively spliced TF is the main source of TF activity released from human cancer cells.  J Thromb Haemost. 2004;  2(11) 2065-2067
  Google Scholar
• 25 Zwicker J I, Furie B C, Furie B. Cancer-associated thrombosis.  Crit Rev Oncol Hematol. 2007;  62(2) 126-136
  Google Scholar
• 26 Aharon A, Brenner B. Microparticles, thrombosis and cancer.  Best Pract Res Clin Haematol. 2009;  22(1) 61-69
  CrossrefPubMedGoogle Scholar
• 27 Diamant M, Tushuizen M E, Sturk A, Nieuwland R. Cellular microparticles: new players in the field of vascular disease?.  Eur J Clin Invest. 2004;  34(6) 392-401
  CrossrefPubMedGoogle Scholar
• 28 Di Vizio D, Kim J, Hager M H et al. Oncosome formation in prostate cancer: association with a region of frequent chromosomal deletion in metastatic disease.  Cancer Res. 2009;  69(13) 5601-5609
  CrossrefPubMedGoogle Scholar
• 29 Tesselaar M E, Romijn F P, Van Der Linden I K, Prins F A, Bertina R M, Osanto S. Microparticle-associated tissue factor activity: a link between cancer and thrombosis?.  J Thromb Haemost. 2007;  5(3) 520-527
  CrossrefPubMedGoogle Scholar
• 30 Burnier L, Fontana P, Kwak B R, Angelillo-Scherrer A. Cell-derived microparticles in haemostasis and vascular medicine.  Thromb Haemost. 2009;  101(3) 439-451
  PubMedGoogle Scholar
• 31 Dolo V, D'Ascenzo S, Giusti I, Millimaggi D, Taraboletti G, Pavan A. Shedding of membrane vesicles by tumor and endothelial cells.  Ital J Anat Embryol. 2005;  110(2, Suppl 1) 127-133
  PubMedGoogle Scholar
• 32 Chargaff E, West R. The biological significance of the thromboplastic protein of blood.  J Biol Chem. 1946;  166(1) 189-197
  PubMedGoogle Scholar
• 33 Wolf P. The nature and significance of platelet products in human plasma.  Br J Haematol. 1967;  13(3) 269-288
  CrossrefPubMedGoogle Scholar
• 34 Dvorak H F, Quay S C, Orenstein N S et al. Tumor shedding and coagulation.  Science. 1981;  212(4497) 923-924
  CrossrefPubMedGoogle Scholar
• 35 Piccin A, Murphy W G, Smith O P. Circulating microparticles: pathophysiology and clinical implications.  Blood Rev. 2007;  21(3) 157-171
  CrossrefPubMedGoogle Scholar
• 36 Valenti R, Huber V, Iero M, Filipazzi P, Parmiani G, Rivoltini L. Tumor-released microvesicles as vehicles of immunosuppression.  Cancer Res. 2007;  67(7) 2912-2915
  CrossrefPubMedGoogle Scholar
• 37 Mayordomo J I, Zorina T, Storkus W J et al. Bone marrow-derived dendritic cells pulsed with synthetic tumour peptides elicit protective and therapeutic antitumour immunity.  Nat Med. 1995;  1(12) 1297-1302
  CrossrefPubMedGoogle Scholar
• 38 Williams R L, Urbé S. The emerging shape of the ESCRT machinery.  Nat Rev Mol Cell Biol. 2007;  8(5) 355-368
  CrossrefPubMedGoogle Scholar
• 39 Simons M, Raposo G. Exosomes—vesicular carriers for intercellular communication.  Curr Opin Cell Biol. 2009;  21(4) 575-581
  CrossrefPubMedGoogle Scholar
• 40 Février B, Raposo G. Exosomes: endosomal-derived vesicles shipping extracellular messages.  Curr Opin Cell Biol. 2004;  16(4) 415-421
  CrossrefPubMedGoogle Scholar
• 41 Houseley J, LaCava J, Tollervey D. RNA-quality control by the exosome.  Nat Rev Mol Cell Biol. 2006;  7(7) 529-539
  CrossrefPubMedGoogle Scholar
• 42 Enjeti A K, Lincz L F, Seldon M. Microparticles in health and disease.  Semin Thromb Hemost. 2008;  34(7) 683-691
  Article in Thieme ConnectPubMedGoogle Scholar
• 43 Lynch S F, Ludlam C A. Plasma microparticles and vascular disorders.  Br J Haematol. 2007;  137(1) 36-48
  PubMedGoogle Scholar
• 44 Nazarenko I, Rana S, Baumann A et al. Cell surface tetraspanin Tspan8 contributes to molecular pathways of exosome-induced endothelial cell activation.  Cancer Res. 2010;  70(4) 1668-1678
  CrossrefPubMedGoogle Scholar
• 45 Ratajczak J, Miekus K, Kucia M et al. Embryonic stem cell-derived microvesicles reprogram hematopoietic progenitors: evidence for horizontal transfer of mRNA and protein delivery.  Leukemia. 2006;  20(5) 847-856
  CrossrefPubMedGoogle Scholar
• 46 Del Conde I, Shrimpton C N, Thiagarajan P, López J A. Tissue-factor-bearing microvesicles arise from lipid rafts and fuse with activated platelets to initiate coagulation.  Blood. 2005;  106(5) 1604-1611
  CrossrefPubMedGoogle Scholar
• 47 Aharon A, Tamari T, Brenner B. Monocyte-derived microparticles and exosomes induce procoagulant and apoptotic effects on endothelial cells.  Thromb Haemost. 2008;  100(5) 878-885
  Article in Thieme ConnectPubMedGoogle Scholar
• 48 Tilley R E, Holscher T, Belani R, Nieva J, Mackman N. Tissue factor activity is increased in a combined platelet and microparticle sample from cancer patients.  Thromb Res. 2008;  122(5) 604-609
  CrossrefPubMedGoogle Scholar
• 49 Castellana D, Zobairi F, Martinez M C et al. Membrane microvesicles as actors in the establishment of a favorable prostatic tumoral niche: a role for activated fibroblasts and CX3CL1-CX3CR1 axis.  Cancer Res. 2009;  69(3) 785-793
  CrossrefPubMedGoogle Scholar
• 50 Doeuvre L, Angles-Cano E. Cell-derived microparticles unveil their fibrinolytic and proteolytic function [in French].  Med Sci (Paris). 2009;  25 37-44
  PubMedGoogle Scholar
• 51 Wysoczynski M, Ratajczak M Z. Lung cancer secreted microvesicles: underappreciated modulators of microenvironment in expanding tumors.  Int J Cancer. 2009;  125(7) 1595-1603
  CrossrefPubMedGoogle Scholar
• 52 Angelucci A, D'Ascenzo S, Festuccia C et al. Vesicle-associated urokinase plasminogen activator promotes invasion in prostate cancer cell lines.  Clin Exp Metastasis. 2000;  18(2) 163-170
  CrossrefPubMedGoogle Scholar
• 53 Gesierich S, Berezovskiy I, Ryschich E, Zöller M. Systemic induction of the angiogenesis switch by the tetraspanin D6.1A/CO-029.  Cancer Res. 2006;  66(14) 7083-7094
  CrossrefPubMedGoogle Scholar
• 54 Janowska-Wieczorek A, Wysoczynski M, Kijowski J et al. Microvesicles derived from activated platelets induce metastasis and angiogenesis in lung cancer.  Int J Cancer. 2005;  113(5) 752-760
  CrossrefPubMedGoogle Scholar
• 55 Deregibus M C, Cantaluppi V, Calogero R et al. Endothelial progenitor cell derived microvesicles activate an angiogenic program in endothelial cells by a horizontal transfer of mRNA.  Blood. 2007;  110(7) 2440-2448
  CrossrefPubMedGoogle Scholar
• 56 Hong B S, Cho J H, Kim H et al. Colorectal cancer cell-derived microvesicles are enriched in cell cycle-related mRNAs that promote proliferation of endothelial cells.  BMC Genomics. 2009;  10 556
  CrossrefPubMedGoogle Scholar
• 57 Hood J L, Pan H, Lanza G M, Wickline S A. Consortium for Translational Research in Advanced Imaging and Nanomedicine (C-TRAIN) . Paracrine induction of endothelium by tumor exosomes.  Lab Invest. 2009;  89(11) 1317-1328
  CrossrefPubMedGoogle Scholar
• 58 Taraboletti G, D'Ascenzo S, Giusti I et al. Bioavailability of VEGF in tumor-shed vesicles depends on vesicle burst induced by acidic pH.  Neoplasia. 2006;  8(2) 96-103
  CrossrefPubMedGoogle Scholar
• 59 Hao S, Ye Z, Li F et al. Epigenetic transfer of metastatic activity by uptake of highly metastatic B16 melanoma cell-released exosomes.  Exp Oncol. 2006;  28(2) 126-131
  PubMedGoogle Scholar
• 60 Jung T, Castellana D, Klingbeil P et al. CD44v6 dependence of premetastatic niche preparation by exosomes.  Neoplasia. 2009;  11(10) 1093-1105
  CrossrefPubMedGoogle Scholar
• 61 Lima L G, Chammas R, Monteiro R Q, Moreira M E, Barcinski M A. Tumor-derived microvesicles modulate the establishment of metastatic melanoma in a phosphatidylserine-dependent manner.  Cancer Lett. 2009;  283(2) 168-175
  CrossrefPubMedGoogle Scholar
• 62 Skog J, Würdinger T, van Rijn S et al. Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers.  Nat Cell Biol. 2008;  10(12) 1470-1476
  CrossrefPubMedGoogle Scholar
• 63 Andreola G, Rivoltini L, Castelli C et al. Induction of lymphocyte apoptosis by tumor cell secretion of FasL-bearing microvesicles.  J Exp Med. 2002;  195(10) 1303-1316
  CrossrefPubMedGoogle Scholar
• 64 Liu Y, Xiang X, Zhuang X et al.. Contribution of MyD88 to the tumor exosome-mediated induction of myeloid derived suppressor cells.  Am J Pathol. 2010;  176(5) 2490-2499
  CrossrefPubMedGoogle Scholar
• 65 Iero M, Valenti R, Huber V et al. Tumour-released exosomes and their implications in cancer immunity.  Cell Death Differ. 2008;  15(1) 80-88
  CrossrefPubMedGoogle Scholar
• 66 Wolfers J, Lozier A, Raposo G et al. Tumor-derived exosomes are a source of shared tumor rejection antigens for CTL cross-priming.  Nat Med. 2001;  7(3) 297-303
  CrossrefPubMedGoogle Scholar
• 67 Koga K, Matsumoto K, Akiyoshi T et al. Purification, characterization and biological significance of tumor-derived exosomes.  Anticancer Res. 2005;  25(6A, 6A) 3703-3707
  PubMedGoogle Scholar
• 68 Gelderman M P, Simak J. Flow cytometric analysis of cell membrane microparticles.  Methods Mol Biol. 2008;  484 79-93
  PubMedGoogle Scholar
• 69 Morel O, Morel N, Freyssinet J M, Toti F. Platelet microparticles and vascular cells interactions: a checkpoint between the haemostatic and thrombotic responses.  Platelets. 2008;  19(1) 9-23
  CrossrefPubMedGoogle Scholar
• 70 Lehmann B D, Paine M S, Brooks A M et al. Senescence-associated exosome release from human prostate cancer cells.  Cancer Res. 2008;  68(19) 7864-7871
  CrossrefPubMedGoogle Scholar
• 71 Bianco F, Perrotta C, Novellino L et al. Acid sphingomyelinase activity triggers microparticle release from glial cells.  EMBO J. 2009;  28(8) 1043-1054
  CrossrefPubMedGoogle Scholar
• 72 Parolini I, Federici C, Raggi C et al. Microenvironmental pH is a key factor for exosome traffic in tumor cells.  J Biol Chem. 2009;  284(49) 34211-34222
  CrossrefPubMedGoogle Scholar
• 73 Park J E, Tan H S, Datta A et al. Hypoxic tumor cell modulates its microenvironment to enhance angiogenic and metastatic potential by secretion of proteins and exosomes.  Mol Cell Proteomics. 2010;  9 1085-1099
  PubMedGoogle Scholar
• 74 Yu J L, May L, Lhotak V et al. Oncogenic events regulate tissue factor expression in colorectal cancer cells: implications for tumor progression and angiogenesis.  Blood. 2005;  105(4) 1734-1741
  CrossrefPubMedGoogle Scholar
• 75 Yu X, Harris S L, Levine A J. The regulation of exosome secretion: a novel function of the p53 protein.  Cancer Res. 2006;  66(9) 4795-4801
  CrossrefPubMedGoogle Scholar
• 76 Muralidharan-Chari V, Clancy J, Plou C et al. ARF6-regulated shedding of tumor cell-derived plasma membrane microvesicles.  Curr Biol. 2009;  19(22) 1875-1885
  CrossrefPubMedGoogle Scholar
• 77 Valadi H, Ekström K, Bossios A, Sjöstrand M, Lee J J, Lötvall J O. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells.  Nat Cell Biol. 2007;  9(6) 654-659
  CrossrefPubMedGoogle Scholar
• 78 Simpson R J, Lim J W, Moritz R L, Mathivanan S. Exosomes: proteomic insights and diagnostic potential.  Expert Rev Proteomics. 2009;  6(3) 267-283
  CrossrefPubMedGoogle Scholar
• 79 Sinauridze E I, Kireev D A, Popenko N Y et al. Platelet microparticle membranes have 50- to 100-fold higher specific procoagulant activity than activated platelets.  Thromb Haemost. 2007;  97(3) 425-434
  Article in Thieme ConnectPubMedGoogle Scholar
• 80 Krishnan L, Sprott G D. Archaeosome adjuvants: immunological capabilities and mechanism(s) of action.  Vaccine. 2008;  26(17) 2043-2055
  CrossrefPubMedGoogle Scholar
• 81 Graner M W, Alzate O, Dechkovskaia A M et al. Proteomic and immunologic analyses of brain tumor exosomes.  FASEB J. 2009;  23(5) 1541-1557
  CrossrefPubMedGoogle Scholar
• 82 Heijnen H F, Schiel A E, Fijnheer R, Geuze H J, Sixma J J. Activated platelets release two types of membrane vesicles: microvesicles by surface shedding and exosomes derived from exocytosis of multivesicular bodies and alpha-granules.  Blood. 1999;  94(11) 3791-3799
  PubMedGoogle Scholar
• 83 Diamandis P, Sacher A G, Tyers M, Dirks P B. New drugs for brain tumors? Insights from chemical probing of neural stem cells.  Med Hypotheses. 2009;  72(6) 683-687
  CrossrefPubMedGoogle Scholar
• 84 Bovellan M, Fritzsche M, Stevens C, Charras G. Death-associated protein kinase (DAPK) and signal transduction: blebbing in programmed cell death.  FEBS J. 2010;  277(1) 58-65
  CrossrefPubMedGoogle Scholar
• 85 Vikkula M, Boon L M, Carraway III K L et al. Vascular dysmorphogenesis caused by an activating mutation in the receptor tyrosine kinase TIE2.  Cell. 1996;  87(7) 1181-1190
  CrossrefPubMedGoogle Scholar
• 86 Ehnfors J, Kost-Alimova M, Persson N L et al. Horizontal transfer of tumor DNA to endothelial cells in vivo.  Cell Death Differ. 2009;  16(5) 749-757
  CrossrefPubMedGoogle Scholar
• 87 Bergsmedh A, Szeles A, Henriksson M et al. Horizontal transfer of oncogenes by uptake of apoptotic bodies.  Proc Natl Acad Sci U S A. 2001;  98(11) 6407-6411
  CrossrefPubMedGoogle Scholar
• 88 Orozco A F, Lewis D E. Flow cytometric analysis of circulating microparticles in plasma.  Cytometry A. 2010;  77(6) 502-514
  PubMedGoogle Scholar
• 89 Simak J, Gelderman M P. Cell membrane microparticles in blood and blood products: potentially pathogenic agents and diagnostic markers.  Transfus Med Rev. 2006;  20(1) 1-26
  CrossrefPubMedGoogle Scholar
• 90 Bianco F, Pravettoni E, Colombo A et al. Astrocyte-derived ATP induces vesicle shedding and IL-1 beta release from microglia.  J Immunol. 2005;  174(11) 7268-7277
  PubMedGoogle Scholar
• 91 Schiera G, Proia P, Alberti C, Mineo M, Savettieri G, Di Liegro I. Neurons produce FGF2 and VEGF and secrete them at least in part by shedding extracellular vesicles.  J Cell Mol Med. 2007;  11(6) 1384-1394
  CrossrefPubMedGoogle Scholar
• 92 Mause S F, von Hundelshausen P, Zernecke A, Koenen R R, Weber C. Platelet microparticles: a transcellular delivery system for RANTES promoting monocyte recruitment on endothelium.  Arterioscler Thromb Vasc Biol. 2005;  25(7) 1512-1518
  CrossrefPubMedGoogle Scholar
• 93 Bevers E M, Williamson P L. Phospholipid scramblase: an update.  FEBS Lett. 2010;  584(13) 2724-2730
  CrossrefPubMedGoogle Scholar
• 94 Taylor R C, Cullen S P, Martin S J. Apoptosis: controlled demolition at the cellular level.  Nat Rev Mol Cell Biol. 2008;  9(3) 231-241
  CrossrefPubMedGoogle Scholar
• 95 Charras G T, Yarrow J C, Horton M A, Mahadevan L, Mitchison T J. Non-equilibration of hydrostatic pressure in blebbing cells.  Nature. 2005;  435(7040) 365-369
  CrossrefPubMedGoogle Scholar
• 96 Tinevez J Y, Schulze U, Salbreux G, Roensch J, Joanny J F, Paluch E. Role of cortical tension in bleb growth.  Proc Natl Acad Sci U S A. 2009;  106(44) 18581-18586
  CrossrefPubMedGoogle Scholar
• 97 Zimmerberg J, Kozlov M M. How proteins produce cellular membrane curvature.  Nat Rev Mol Cell Biol. 2006;  7(1) 9-19
  CrossrefPubMedGoogle Scholar
• 98 Toth B, Nikolajek K, Rank A et al. Gender-specific and menstrual cycle dependent differences in circulating microparticles.  Platelets. 2007;  18(7) 515-521
  CrossrefPubMedGoogle Scholar
• 99 Madden L A, Vince R V, Sandström M E, Taylor L, McNaughton L, Laden G. Microparticle-associated vascular adhesion molecule-1 and tissue factor follow a circadian rhythm in healthy human subjects.  Thromb Haemost. 2008;  99(5) 909-915
  PubMedGoogle Scholar
• 100 Zwaal R F, Comfurius P, Bevers E M. Scott syndrome, a bleeding disorder caused by defective scrambling of membrane phospholipids.  Biochim Biophys Acta. 2004;  1636(2-3) 119-128
  CrossrefPubMedGoogle Scholar
• 101 Zhou Q, Zhao J, Wiedmer T, Sims P J. Normal hemostasis but defective hematopoietic response to growth factors in mice deficient in phospholipid scramblase 1.  Blood. 2002;  99(11) 4030-4038
  CrossrefPubMedGoogle Scholar
• 102 Rak J, Yu J L, Luyendyk J, Mackman N. Oncogenes, Trousseau syndrome, and cancer-related changes in the coagulome of mice and humans.  Cancer Res. 2006;  66(22) 10643-10646
  CrossrefPubMedGoogle Scholar
• 103 Huang X, Bennett M, Thorpe P E. A monoclonal antibody that binds anionic phospholipids on tumor blood vessels enhances the antitumor effect of docetaxel on human breast tumors in mice.  Cancer Res. 2005;  65(10) 4408-4416
  CrossrefPubMedGoogle Scholar
• 104 Trajkovic K, Hsu C, Chiantia S et al. Ceramide triggers budding of exosome vesicles into multivesicular endosomes.  Science. 2008;  319(5867) 1244-1247
  CrossrefPubMedGoogle Scholar
• 105 Murphy J E, Padilla B E, Hasdemir B, Cottrell G S, Bunnett N W. Endosomes: a legitimate platform for the signaling train.  Proc Natl Acad Sci U S A. 2009;  106(42) 17615-17622
  CrossrefPubMedGoogle Scholar
• 106 Hegmans J P, Gerber P J, Lambrecht B N. Exosomes.  Methods Mol Biol. 2008;  484 97-109
  PubMedGoogle Scholar
• 107 Zöller M. Tetraspanins: push and pull in suppressing and promoting metastasis.  Nat Rev Cancer. 2009;  9(1) 40-55
  CrossrefPubMedGoogle Scholar
• 108 Poliakov A, Spilman M, Dokland T, Amling C L, Mobley J A. Structural heterogeneity and protein composition of exosome-like vesicles (prostasomes) in human semen.  Prostate. 2009;  69(2) 159-167
  CrossrefPubMedGoogle Scholar
• 109 Sanderson M P, Keller S, Alonso A, Riedle S, Dempsey P J, Altevogt P. Generation of novel, secreted epidermal growth factor receptor (EGFR/ErbB1) isoforms via metalloprotease-dependent ectodomain shedding and exosome secretion.  J Cell Biochem. 2008;  103(6) 1783-1797
  CrossrefPubMedGoogle Scholar
• 110 Milsom C C, Yu J L, Mackman N et al. Tissue factor regulation by epidermal growth factor receptor and epithelial-to-mesenchymal transitions: effect on tumor initiation and angiogenesis.  Cancer Res. 2008;  68(24) 10068-10076
  CrossrefPubMedGoogle Scholar
• 111 Marzesco A M, Janich P, Wilsch-Bräuninger M et al. Release of extracellular membrane particles carrying the stem cell marker prominin-1 (CD133) from neural progenitors and other epithelial cells.  J Cell Sci. 2005;  118(Pt 13) 2849-2858
  CrossrefPubMedGoogle Scholar
• 112 Hron G, Kollars M, Weber H et al. Tissue factor-positive microparticles: cellular origin and association with coagulation activation in patients with colorectal cancer.  Thromb Haemost. 2007;  97(1) 119-123
  Google Scholar
• 113 Mack M, Kleinschmidt A, Brühl H et al. Transfer of the chemokine receptor CCR5 between cells by membrane-derived microparticles: a mechanism for cellular human immunodeficiency virus 1 infection.  Nat Med. 2000;  6(7) 769-775
  CrossrefPubMedGoogle Scholar
• 114 Iwamura M, di Sant'Agnese P A, Wu G et al. Immunohistochemical localization of parathyroid hormone-related protein in human prostate cancer.  Cancer Res. 1993;  53(8) 1724-1726
  PubMedGoogle Scholar
• 115 Monleón I, Martínez-Lorenzo M J, Monteagudo L et al. Differential secretion of Fas ligand- or APO2 ligand/TNF-related apoptosis-inducing ligand-carrying microvesicles during activation-induced death of human T cells.  J Immunol. 2001;  167(12) 6736-6744
  PubMedGoogle Scholar
• 116 Kim J W, Wieckowski E, Taylor D D, Reichert T E, Watkins S, Whiteside T L. Fas ligand-positive membranous vesicles isolated from sera of patients with oral cancer induce apoptosis of activated T lymphocytes.  Clin Cancer Res. 2005;  11(3) 1010-1020
  PubMedGoogle Scholar
• 117 Huber V, Fais S, Iero M et al. Human colorectal cancer cells induce T-cell death through release of proapoptotic microvesicles: role in immune escape.  Gastroenterology. 2005;  128(7) 1796-1804
  CrossrefPubMedGoogle Scholar
• 118 Greco V, Hannus M, Eaton S. Argosomes: a potential vehicle for the spread of morphogens through epithelia.  Cell. 2001;  106(5) 633-645
  CrossrefPubMedGoogle Scholar
• 119 Reya T, Clevers H. Wnt signalling in stem cells and cancer.  Nature. 2005;  434(7035) 843-850
  CrossrefPubMedGoogle Scholar
• 120 Taipale J, Beachy P A. The Hedgehog and Wnt signalling pathways in cancer.  Nature. 2001;  411(6835) 349-354
  CrossrefPubMedGoogle Scholar
• 121 Martínez M C, Larbret F, Zobairi F et al. Transfer of differentiation signal by membrane microvesicles harboring hedgehog morphogens.  Blood. 2006;  108(9) 3012-3020
  CrossrefPubMedGoogle Scholar
• 122 Morel O, Toti F, Morel N, Freyssinet J M. Microparticles in endothelial cell and vascular homeostasis: are they really noxious?.  Haematologica. 2009;  94(3) 313-317
  CrossrefPubMedGoogle Scholar
• 123 Korkut C, Ataman B, Ramachandran P et al. Trans-synaptic transmission of vesicular Wnt signals through Evi/Wntless.  Cell. 2009;  139(2) 393-404
  CrossrefPubMedGoogle Scholar
• 124 Poupot M, Fournié J J. Spontaneous membrane transfer through homotypic synapses between lymphoma cells.  J Immunol. 2003;  171(5) 2517-2523
  PubMedGoogle Scholar
• 125 Dolo V, Ginestra A, Cassarà D et al. Selective localization of matrix metalloproteinase 9, beta1 integrins, and human lymphocyte antigen class I molecules on membrane vesicles shed by 8701-BC breast carcinoma cells.  Cancer Res. 1998;  58(19) 4468-4474
  PubMedGoogle Scholar
• 126 Barry O P, Pratico D, Lawson J A, FitzGerald G A. Transcellular activation of platelets and endothelial cells by bioactive lipids in platelet microparticles.  J Clin Invest. 1997;  99(9) 2118-2127
  CrossrefPubMedGoogle Scholar
• 127 Rak J, Yu J L, Klement G, Kerbel R S. Oncogenes and angiogenesis: signaling three-dimensional tumor growth.  J Investig Dermatol Symp Proc. 2000;  5(1) 24-33
  CrossrefPubMedGoogle Scholar
• 128 Yu J, May L, Milsom C et al. Contribution of host-derived tissue factor to tumor neovascularization.  Arterioscler Thromb Vasc Biol. 2008;  28(11) 1975-1981
  CrossrefPubMedGoogle Scholar
• 129 Falati S, Liu Q, Gross P et al. Accumulation of tissue factor into developing thrombi in vivo is dependent upon microparticle P-selectin glycoprotein ligand 1 and platelet P-selectin.  J Exp Med. 2003;  197(11) 1585-1598
  CrossrefPubMedGoogle Scholar
• 130 Landsverk T, Trevella W, Nicander L. Transfer of carbonic anhydrase-positive particles from the follicle-associated epithelium to lymphocytes of Peyer's patches in foetal sheep and lambs.  Cell Tissue Res. 1990;  261(2) 239-247
  CrossrefPubMedGoogle Scholar
• 131 Liu R, Klich I, Ratajczak J, Ratajczak M Z, Zuba-Surma E K. Erythrocyte-derived microvesicles may transfer phosphatidylserine to the surface of nucleated cells and falsely ‘mark’ them as apoptotic.  Eur J Haematol. 2009;  83(3) 220-229
  CrossrefPubMedGoogle Scholar
• 132 Milsom C, Magnus N, Meehan B, Al-Nedawi K, Garnier D, Rak J. Tissue factor and cancer stem cells: is there a linkage?.  Arterioscler Thromb Vasc Biol. 2009;  29(12) 2005-2014
  CrossrefPubMedGoogle Scholar
• 133 Delves G H, Stewart A B, Cooper A J, Lwaleed B A. Prostasomes, angiogenesis, and tissue factor.  Semin Thromb Hemost. 2007;  33(1) 75-79
  Article in Thieme ConnectPubMedGoogle Scholar
• 134 Simpson R J, Jensen S S, Lim J W. Proteomic profiling of exosomes: current perspectives.  Proteomics. 2008;  8(19) 4083-4099
  CrossrefPubMedGoogle Scholar
• 135 Banfi C, Brioschi M, Barcella S et al. Tissue factor induction by protease-activated receptor 1 requires intact caveolin-enriched membrane microdomains in human endothelial cells.  J Thromb Haemost. 2007;  5(12) 2437-2444
  CrossrefPubMedGoogle Scholar
• 136 Mathivanan S, Lim J W, Tauro B J, Ji H, Moritz R L, Simpson R J. Proteomics analysis of A33 immunoaffinity-purified exosomes released from the human colon tumor cell line LIM1215 reveals a tissue-specific protein signature.  Mol Cell Proteomics. 2010;  9(2) 197-208
  PubMedGoogle Scholar
• 137 Choi D S, Lee J M, Park G W et al. Proteomic analysis of microvesicles derived from human colorectal cancer cells.  J Proteome Res. 2007;  6(12) 4646-4655
  CrossrefPubMedGoogle Scholar
• 138 Chen C, Skog J, Hsu C H et al. Microfluidic isolation and transcriptome analysis of serum microvesicles.  Lab Chip. 2010;  10(4) 505-511
  CrossrefPubMedGoogle Scholar
• 139 Thomas G M, Panicot-Dubois L, Lacroix R, Dignat-George F, Lombardo D, Dubois C. Cancer cell-derived microparticles bearing P-selectin glycoprotein ligand 1 accelerate thrombus formation in vivo.  J Exp Med. 2009;  206(9) 1913-1927
  CrossrefPubMedGoogle Scholar
• 140 Gross P L, Furie B C, Merrill-Skoloff G, Chou J, Furie B. Leukocyte-versus microparticle-mediated tissue factor transfer during arteriolar thrombus development.  J Leukoc Biol. 2005;  78(6) 1318-1326
  CrossrefPubMedGoogle Scholar
• 141 Zhou Z. New phosphatidylserine receptors: clearance of apoptotic cells and more.  Dev Cell. 2007;  13(6) 759-760
  CrossrefPubMedGoogle Scholar
• 142 Park D, Tosello-Trampont A C, Elliott M R et al. BAI1 is an engulfment receptor for apoptotic cells upstream of the ELMO/Dock180/Rac module.  Nature. 2007;  450(7168) 430-434
  CrossrefPubMedGoogle Scholar
• 143 Nishimori H, Shiratsuchi T, Urano T et al. A novel brain-specific p53-target gene, BAI1, containing thrombospondin type 1 repeats inhibits experimental angiogenesis.  Oncogene. 1997;  15(18) 2145-2150
  CrossrefPubMedGoogle Scholar
• 144 McMahon H T, Kozlov M M, Martens S. Membrane curvature in synaptic vesicle fusion and beyond.  Cell. 2010;  140(5) 601-605
  CrossrefPubMedGoogle Scholar
• 145 Key N S, Chantrathammachart P, Moody P W, Chang J-Y. Membrane microparticles in VTE and cancer.  Thromb Res. 2010;  125(Suppl 2) S80-S83
  CrossrefPubMedGoogle Scholar
• 146 Zwicker J I. Predictive value of tissue factor bearing microparticles in cancer associated thrombosis.  Thromb Res. 2010;  125(Suppl 2) S89-S91
  CrossrefPubMedGoogle Scholar
• 147 Castellana D, Toti F, Freyssinet J M. Membrane microvesicles: macromessengers in cancer disease and progression.  Thromb Res. 2010;  125(Suppl 2) S84-S88
  CrossrefPubMedGoogle Scholar
• 148 Falanga A. Thrombophilia in cancer.  Semin Thromb Hemost. 2005;  31(1) 104-110
  Article in Thieme ConnectPubMedGoogle Scholar
• 149 Rickles F R. Mechanisms of cancer-induced thrombosis in cancer.  Pathophysiol Haemost Thromb. 2006;  35(1–2) 103-110
  CrossrefPubMedGoogle Scholar
• 150 Lee A Y. Cancer and thromboembolic disease: pathogenic mechanisms.  Cancer Treat Rev. 2002;  28(3) 137-140
  CrossrefPubMedGoogle Scholar
• 151 Buller H R, van Doormaal F F, van Sluis G L, Kamphuisen P W. Cancer and thrombosis: from molecular mechanisms to clinical presentations.  J Thromb Haemost. 2007;  5(Suppl 1) 246-254
  CrossrefPubMedGoogle Scholar
• 152 Trousseau A. Phlegmasia alba dolens. 2nd ed. Clinique Medicale de L'Hotel-Dieu de Paris. Paris, France; Bailliere 1865: 654-712
  Google Scholar
• 153 Khorana A A, Francis C W, Menzies K E et al. Plasma tissue factor may be predictive of venous thromboembolism in pancreatic cancer.  J Thromb Haemost. 2008;  6(11) 1983-1985
  CrossrefPubMedGoogle Scholar
• 154 Boccaccio C, Sabatino G, Medico E et al. The MET oncogene drives a genetic programme linking cancer to haemostasis.  Nature. 2005;  434(7031) 396-400
  CrossrefPubMedGoogle Scholar
• 155 Rak J, Klement G. Impact of oncogenes and tumor suppressor genes on deregulation of hemostasis and angiogenesis in cancer.  Cancer Metastasis Rev. 2000;  19(1-2) 93-96
  CrossrefPubMedGoogle Scholar
• 156 Milsom C, Anderson G M, Weitz J I, Rak J. Elevated tissue factor procoagulant activity in CD133-positive cancer cells.  J Thromb Haemost. 2007;  5(12) 2550-2552
  CrossrefPubMedGoogle Scholar
• 157 Tallman M S, Lefèbvre P, Baine R M et al. Effects of all-trans retinoic acid or chemotherapy on the molecular regulation of systemic blood coagulation and fibrinolysis in patients with acute promyelocytic leukemia.  J Thromb Haemost. 2004;  2(8) 1341-1350
  CrossrefPubMedGoogle Scholar
• 158 Russo L, Mandala M, Marchetti A et al. Loss of angiogenic activity and improvement of hemostatic variables in patients with gastrointestinal stromal tumors (GIST) under imatinib therapy: a biological evaluation [abstract].  Thromb Res. 2010;  125 S175
  PubMedGoogle Scholar
• 159 Giesen P L, Rauch U, Bohrmann B et al. Blood-borne tissue factor: another view of thrombosis.  Proc Natl Acad Sci U S A. 1999;  96(5) 2311-2315
  CrossrefPubMedGoogle Scholar
• 160 Rauch U, Antoniak S. Tissue factor-positive microparticles in blood associated with coagulopathy in cancer.  Thromb Haemost. 2007;  97(1) 9-10
  PubMedGoogle Scholar
• 161 Contrino J, Hair G, Kreutzer D L, Rickles F R. In situ detection of tissue factor in vascular endothelial cells: correlation with the malignant phenotype of human breast disease.  Nat Med. 1996;  2(2) 209-215
  CrossrefPubMedGoogle Scholar
• 162 Rak J, Milsom C, Yu J. Tissue factor in cancer.  Curr Opin Hematol. 2008;  15(5) 522-528
  CrossrefPubMedGoogle Scholar
• 163 Kuypers F A, Larkin S K, Emeis J J, Allison A C. Interaction of an annexin V homodimer (Diannexin) with phosphatidylserine on cell surfaces and consequent antithrombotic activity.  Thromb Haemost. 2007;  97(3) 478-486
  PubMedGoogle Scholar
• 164 Lacroix R, Sabatier F, Mialhe A et al. Activation of plasminogen into plasmin at the surface of endothelial microparticles: a mechanism that modulates angiogenic properties of endothelial progenitor cells in vitro.  Blood. 2007;  110(7) 2432-2439
  CrossrefPubMedGoogle Scholar
• 165 Sabatier F, Camoin-Jau L, Anfosso F, Sampol J, Dignat-George F. Circulating endothelial cells, microparticles and progenitors: key players towards the definition of vascular competence.  J Cell Mol Med. 2009;  13(3) 454-471
  CrossrefPubMedGoogle Scholar
• 166 Kim C W, Lee H M, Lee T H, Kang C, Kleinman H K, Gho Y S. Extracellular membrane vesicles from tumor cells promote angiogenesis via sphingomyelin.  Cancer Res. 2002;  62(21) 6312-6317
  PubMedGoogle Scholar
• 167 Kim H K, Song K S, Chung J H, Lee K R, Lee S N. Platelet microparticles induce angiogenesis in vitro.  Br J Haematol. 2004;  124(3) 376-384
  CrossrefPubMedGoogle Scholar
• 168 Rhee J S, Black M, Schubert U et al. The functional role of blood platelet components in angiogenesis.  Thromb Haemost. 2004;  92(2) 394-402
  PubMedGoogle Scholar
• 169 Aoki N, Yokoyama R, Asai N et al. Adipocyte-derived microvesicles are associated with multiple angiogenic factors and induce angiogenesis in vivo and in vitro.  Endocrinology. 2010;  151(6) 2567-2576
  CrossrefPubMedGoogle Scholar
• 170 Smalheiser N R. Do neural cells communicate with endothelial cells via secretory exosomes and microvesicles?.  Cardiovasc Psychiatry Neurol. 2009;  , August 3 (Epub ahead of print)
  PubMedGoogle Scholar
• 171 Folkman J. Tumor angiogenesis: therapeutic implications.  N Engl J Med. 1971;  285(21) 1182-1186
  CrossrefPubMedGoogle Scholar
• 172 Folkman J. Angiogenesis: an organizing principle for drug discovery?.  Nat Rev Drug Discov. 2007;  6(4) 273-286
  CrossrefPubMedGoogle Scholar
• 173 Ferrara N, Hillan K J, Gerber H P, Novotny W. Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer.  Nat Rev Drug Discov. 2004;  3(5) 391-400
  CrossrefPubMedGoogle Scholar
• 174 Browder T, Folkman J, Pirie-Shepherd S. The hemostatic system as a regulator of angiogenesis.  J Biol Chem. 2000;  275(3) 1521-1524
  CrossrefPubMedGoogle Scholar
• 175 Zangari M, Fink L M, Elice F, Zhan F, Adcock D M, Tricot G J. Thrombotic events in patients with cancer receiving antiangiogenesis agents.  J Clin Oncol. 2009;  27(29) 4865-4873
  CrossrefPubMedGoogle Scholar
• 176 Folkman J, Kalluri R. Tumor angiogenesis. In: Kufe DW, Pollock RE, Weichselbaum RR, et al Cancer Medicine. Hamilton, Ontario, Canada; BC Decker 2003: 161-194
  Google Scholar
• 177 Carmeliet P. Mechanisms of angiogenesis and arteriogenesis.  Nat Med. 2000;  6(4) 389-395
  CrossrefPubMedGoogle Scholar
• 178 Kerbel R S. Tumor angiogenesis.  N Engl J Med. 2008;  358(19) 2039-2049
  CrossrefPubMedGoogle Scholar
• 179 Carmeliet P, De Smet F, Loges S, Mazzone M. Branching morphogenesis and antiangiogenesis candidates: tip cells lead the way.  Nat Rev Clin Oncol. 2009;  6(6) 315-326
  CrossrefPubMedGoogle Scholar
• 180 Rak J, Kerbel R S. Oncogenes and tumor angiogenesis. In: Rak J Oncogene-Directed Therapies. Totowa, NJ; Humana Press 2003: 171-218
  Google Scholar
• 181 Pettersson A, Nagy J A, Brown L F et al. Heterogeneity of the angiogenic response induced in different normal adult tissues by vascular permeability factor/vascular endothelial growth factor.  Lab Invest. 2000;  80(1) 99-115
  CrossrefPubMedGoogle Scholar
• 182 Döme B, Hendrix M J, Paku S, Tóvári J, Tímár J. Alternative vascularization mechanisms in cancer: pathology and therapeutic implications.  Am J Pathol. 2007;  170(1) 1-15
  CrossrefPubMedGoogle Scholar
• 183 Pinedo H M, Verheul H M, D'Amato R J, Folkman J. Involvement of platelets in tumour angiogenesis?.  Lancet. 1998;  352(9142) 1775-1777
  CrossrefPubMedGoogle Scholar
• 184 Klement G L, Yip T T, Cassiola F et al. Platelets actively sequester angiogenesis regulators.  Blood. 2009;  113(12) 2835-2842
  CrossrefPubMedGoogle Scholar
• 185 Varon D, Shai E. Role of platelet-derived microparticles in angiogenesis and tumor progression.  Discov Med. 2009;  8(43) 237-241
  PubMedGoogle Scholar
• 186 Thurston G, Noguera-Troise I, Yancopoulos G D. The Delta paradox: DLL4 blockade leads to more tumour vessels but less tumour growth.  Nat Rev Cancer. 2007;  7(5) 327-331
  CrossrefPubMedGoogle Scholar
• 187 Dvorak H F, Dvorak A M, Manseau E J, Wiberg L, Churchill W H. Fibrin gel investment associated with line 1 and line 10 solid tumor growth, angiogenesis, and fibroplasia in guinea pigs. Role of cellular immunity, myofibroblasts, microvascular damage, and infarction in line 1 tumor regression.  J Natl Cancer Inst. 1979;  62(6) 1459-1472
  PubMedGoogle Scholar
• 188 Rickles F R, Shoji M, Abe K. The role of the hemostatic system in tumor growth, metastasis, and angiogenesis: tissue factor is a bifunctional molecule capable of inducing both fibrin deposition and angiogenesis in cancer.  Int J Hematol. 2001;  73(2) 145-150
  CrossrefPubMedGoogle Scholar
• 189 Belting M, Ahamed J, Ruf W. Signaling of the tissue factor coagulation pathway in angiogenesis and cancer.  Arterioscler Thromb Vasc Biol. 2005;  25(8) 1545-1550
  CrossrefPubMedGoogle Scholar
• 190 Carmeliet P, Mackman N, Moons L et al. Role of tissue factor in embryonic blood vessel development.  Nature. 1996;  383(6595) 73-75
  CrossrefPubMedGoogle Scholar
• 191 Holash J, Maisonpierre P C, Compton D et al. Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF.  Science. 1999;  284(5422) 1994-1998
  CrossrefPubMedGoogle Scholar
• 192 Millimaggi D, Mari M, D'Ascenzo S et al. Tumor vesicle-associated CD147 modulates the angiogenic capability of endothelial cells.  Neoplasia. 2007;  9(4) 349-357
  CrossrefPubMedGoogle Scholar
• 193 Brill A, Dashevsky O, Rivo J, Gozal Y, Varon D. Platelet-derived microparticles induce angiogenesis and stimulate post-ischemic revascularization.  Cardiovasc Res. 2005;  67(1) 30-38
  CrossrefPubMedGoogle Scholar
• 194 Mostefai H A, Andriantsitohaina R, Martínez M C. Plasma membrane microparticles in angiogenesis: role in ischemic diseases and in cancer.  Physiol Res. 2008;  57(3) 311-320
  PubMedGoogle Scholar
• 195 Tsopanoglou N E, Maragoudakis M E. Role of thrombin in angiogenesis and tumor progression.  Semin Thromb Hemost. 2004;  30(1) 63-69
  Article in Thieme ConnectPubMedGoogle Scholar
• 196 Furnari F B, Fenton T, Bachoo R M et al. Malignant astrocytic glioma: genetics, biology, and paths to treatment.  Genes Dev. 2007;  21(21) 2683-2710
  CrossrefPubMedGoogle Scholar
• 197 Candela M E, Geraci F, Turturici G, Taverna S, Albanese I, Sconzo G. Membrane vesicles containing matrix metalloproteinase-9 and fibroblast growth factor-2 are released into the extracellular space from mouse mesoangioblast stem cells.  J Cell Physiol. 2010;  224(1) 144-151
  PubMedGoogle Scholar
• 198 Taverna S, Ghersi G, Ginestra A et al. Shedding of membrane vesicles mediates fibroblast growth factor-2 release from cells.  J Biol Chem. 2003;  278(51) 51911-51919
  CrossrefPubMedGoogle Scholar
• 199 Gibbings D J, Ciaudo C, Erhardt M et al.. Multivesicular bodies associate with components of miRNA effector complexes and modulate miRNA activity.  Nature Cell Biol. 2009;  11 1143-1149
  CrossrefPubMedGoogle Scholar
• 200 Inui M, Martello G, Piccolo S. MicroRNA control of signal transduction.  Nat Rev Mol Cell Biol. 2010;  11(4) 252-263
  CrossrefPubMedGoogle Scholar
• 201 Croce C M. Oncogenes and cancer.  N Engl J Med. 2008;  358(5) 502-511
  CrossrefPubMedGoogle Scholar
• 202 Gasser O, Schifferli J A. Activated polymorphonuclear neutrophils disseminate anti-inflammatory microparticles by ectocytosis.  Blood. 2004;  104(8) 2543-2548
  CrossrefPubMedGoogle Scholar
• 203 Maass N, Hojo T, Zhang M, Sager R, Jonat W, Nagasaki K. Maspin—a novel protease inhibitor with tumor-suppressing activity in breast cancer.  Acta Oncol. 2000;  39(8) 931-934
  CrossrefPubMedGoogle Scholar
• 204 Minetti G, Ciana A, Balduini C. Differential sorting of tyrosine kinases and phosphotyrosine phosphatases acting on band 3 during vesiculation of human erythrocytes.  Biochem J. 2004;  377(Pt 2) 489-497
  CrossrefPubMedGoogle Scholar
• 205 Coren L V, Shatzer T, Ott D E. CD45 immunoaffinity depletion of vesicles from Jurkat T cells demonstrates that exosomes contain CD45: no evidence for a distinct exosome/HIV-1 budding pathway.  Retrovirology. 2008;  5 64
  CrossrefPubMedGoogle Scholar
• 206 Sbai O, Ferhat L, Bernard A et al. Vesicular trafficking and secretion of matrix metalloproteinases-2, -9 and tissue inhibitor of metalloproteinases-1 in neuronal cells.  Mol Cell Neurosci. 2008;  39(4) 549-568
  CrossrefPubMedGoogle Scholar
• 207 Pérez-Casal M, Downey C, Cutillas-Moreno B, Zuzel M, Fukudome K, Toh C H. Microparticle-associated endothelial protein C receptor and the induction of cytoprotective and anti-inflammatory effects.  Haematologica. 2009;  94(3) 387-394
  CrossrefPubMedGoogle Scholar
• 208 Baj-Krzyworzeka M, Majka M, Pratico D et al. Platelet-derived microparticles stimulate proliferation, survival, adhesion, and chemotaxis of hematopoietic cells.  Exp Hematol. 2002;  30(5) 450-459
  CrossrefPubMedGoogle Scholar
• 209 Coussens L M, Werb Z. Inflammation and cancer.  Nature. 2002;  420(6917) 860-867
  CrossrefPubMedGoogle Scholar
• 210 Kalas W, Yu J L, Milsom C et al. Oncogenes and angiogenesis: down-regulation of thrombospondin-1 in normal fibroblasts exposed to factors from cancer cells harboring mutant ras.  Cancer Res. 2005;  65(19) 8878-8886
  CrossrefPubMedGoogle Scholar
• 211 Heppner G H. Tumor heterogeneity.  Cancer Res. 1984;  44(6) 2259-2265
  PubMedGoogle Scholar
• 212 Mellinghoff I K, Wang M Y, Vivanco I et al. Molecular determinants of the response of glioblastomas to EGFR kinase inhibitors.  N Engl J Med. 2005;  353(19) 2012-2024
  CrossrefPubMedGoogle Scholar

Janusz RakM.D. Ph.D. 

Montreal Children's Hospital Research Institute, McGill University

4060 Sainte Catherine West, Montreal, QC H3Z 2Z3, Canada

Email: janusz.rak@mcgill.ca